Confarma

Executive Committee

Executive Committee

  • Karen J. Huebscher

    Chief Executive Officer

    Karen Huebscher has been Chief Executive Officer (CEO) of Solvias since spring 2014. Under her leadership Solvias is underpinning its focus on customer needs, its commitment to technological and know-how leadership, and a drive towards further international expansion.

    Prior to serving as CEO, Karen was a non-executive Board member of Solvias AG from 2013 to 2014. She spent more than 15 years with Novartis in senior leadership positions.

    Karen is a member of the Board of Directors of the Tecan Group. She holds a PhD from the Swiss Institute of Technology in Zurich and an MBA from the IMD in Lausanne.

  • Stefan A. Krügel

    Executive VP, Head of Analytical Services

    Stefan Krügel is Executive Vice President and Head of Analytical Services. He joined Solvias in 2009. Previously, he was Head of Analytical Development, Division Actives and Process Management, Division Actives at Siegfried AG, Zofingen. Prior to this, he worked for InfraServ GmbH & Co. Knapsack KG (successor organization of Hoechst AG) as Business Unit Head Analytical Services and for Clariant Deutschland GmbH, BU Pigments and Additives, BL Flame Retardants as Head of Quality Systems.

    Stefan graduated from Philipps-Universität Marburg, Germany, where he also attained his PhD in Physical Chemistry. He holds an Executive MBA from the University of Zurich.

  • Hans Van Nuffel

    Executive VP, Head of Confarma, Analytical Technology, M&A, Procurement and Facility Management

    Hans Van Nuffel joined Solvias in 2012 and is Executive Vice President, responsible for Confarma in France, Analytical Technologies, Mergers & Acquisitions, Procurement and Facility Management. Prior to Solvias, he was Head of Operations at Acino Pharma AG for three years, where he ran two solid dosage production sites in Switzerland specialising in controlled release. This was preceded by a number of senior positions in the pharmaceutical industry including Fareva Holding, Luxembourg; Excelvision, France; Ciba Vision Faure (Novartis), France. Hans holds a master’s degree in Applied Economics, with majors in Marketing and Finance, from the University of Louvain (Belgium). He is a graduate of INSEAD, International Executive Program Fontainebleau & Singapore and also holds an Executive MBA from the Flanders Business School.

  • Urs Siegrist

    Executive VP, Head of Ligands & Specialty Products

    Urs Siegrist is Executive Vice President and responsible for the Ligands & Speciality Products business. He acquired his broad professional experience in different managerial and technical positions with Ciba-Geigy and Novartis. Urs has extensive knowledge and experience in organic synthesis, especially catalytic methods; heterogeneous and homogeneous catalysis; R&D Services for chemical intermediates, AIs and APIs; pressure reactions and fluorine chemistry; custom synthesis and manufacturing. He holds numerous patents and patent applications in the industrial application of catalytic technology development. Urs has a degree in Chemical Engineering from the Basel Institute of Technology.